Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
41.17
+0.37 (0.91%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Nektar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Raymond James No rating | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 8, 2026 |
| Citi | Citi | Buy Reiterates $151 | Buy | Reiterates | $151 | +266.77% | Oct 5, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Maintains $150 | Buy | Maintains | $150 | +264.34% | Oct 2, 2026 |
| Jefferies | Jefferies | Buy Maintains $150 | Buy | Maintains | $150 | +264.34% | Oct 1, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $185 | Buy | Maintains | $185 | +349.36% | Oct 1, 2026 |
| BTIG | BTIG | Buy Maintains $178 | Buy | Maintains | $178 | +332.35% | Sep 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $153 | Buy | Maintains | $153 | +271.63% | Sep 28, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.